SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-19-000154
Filing Date
2019-01-17
Accepted
2019-01-17 16:58:21
Documents
1
Group Members
LVP GP III, LLCLVP III ASSOCIATES, L.P.LVP III PARTNERS, L.P.LVP LIFE SCIENCE VENTURES III, L.P.LVPMC, LLCPATRICK F. LATTERELL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A lvp_13ga2.htm SC 13G/A 104855
  Complete submission text file 0001683168-19-000154.txt   106679
Mailing Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446
Business Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446 415-399-9880
LVP LIFE SCIENCE VENTURES III L.P. (Filed by) CIK: 0001332654 (see all company filings)

IRS No.: 203061469 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87872 | Film No.: 19531434
SIC: 2834 Pharmaceutical Preparations